IBANDRONATE SODIUM (Alvogen Inc.)
Welcome to the PulseAid listing for the IBANDRONATE SODIUM drug offered from Alvogen Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen Inc. |
NON-PROPRIETARY NAME: | IBANDRONATE SODIUM |
SUBSTANCE NAME: | IBANDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-05-01 |
END MARKETING DATE: | 0000-00-00 |
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG Details:
Item Description | IBANDRONATE SODIUM from Alvogen Inc. |
LABELER NAME: | Alvogen Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2014-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-103_93d541f4-0c4b-3002-17b4-511ded18489d |
PRODUCT NDC: | 47781-103 |
APPLICATION NUMBER: | ANDA078998 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: